Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
Titel:
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
Auteur:
Molife, L. Rhoda Rudman, Sarah M. Alam, Salma Tan, Daniel S.-W. Kristeleit, Hartmut Middleton, Gary Propper, David Bent, Liz Stopfer, Peter Uttenreuther-Fischer, Martina Wallenstein, Gudrun de Bono, Johann Spicer, James